The store will not work correctly when cookies are disabled.
1-(benzo[d][1,3]dioxol-5-ylmethyl)-N-benzyl-1,4-dihydroquinazolin-2-amine
ID: ALA3978715
PubChem CID: 134151527
Max Phase: Preclinical
Molecular Formula: C23H21N3O2
Molecular Weight: 371.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(CNC2=NCc3ccccc3N2Cc2ccc3c(c2)OCO3)cc1
Standard InChI: InChI=1S/C23H21N3O2/c1-2-6-17(7-3-1)13-24-23-25-14-19-8-4-5-9-20(19)26(23)15-18-10-11-21-22(12-18)28-16-27-21/h1-12H,13-16H2,(H,24,25)
Standard InChI Key: CWDWGKJQNBEROO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
13.5141 -7.9384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2274 -7.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2308 -6.7038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5166 -6.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8032 -6.6980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0891 -6.2868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3716 -6.6964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3682 -7.5213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0823 -7.9368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7999 -7.5272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5107 -8.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9416 -7.9442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6550 -7.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3691 -7.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3699 -8.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0799 -9.1863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7975 -8.7766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8008 -7.9517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0867 -7.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7946 -9.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0837 -8.7566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0821 -10.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7948 -9.9953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3643 -9.9914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3647 -9.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5810 -8.9124 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0964 -9.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5805 -10.2456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
1 11 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
12 13 1 0
2 12 1 0
11 20 1 0
20 21 2 0
21 25 1 0
24 22 1 0
22 23 2 0
23 20 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 371.44 | Molecular Weight (Monoisotopic): 371.1634 | AlogP: 4.08 | #Rotatable Bonds: 4 |
Polar Surface Area: 46.09 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.61 | CX LogP: 4.44 | CX LogD: 2.44 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.75 | Np Likeness Score: -0.69 |
References
1. McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.. (2016) Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors' binding pocket., 123 [PMID:27474922] [10.1016/j.ejmech.2016.07.011] |